The title compound 6-amino-3-benzylmercapto-1,2,4-triazolo[3,4-f][1,2,4]-triazin-8(7H)-one (4), molecular formula C(11)H(10)N(6)OS, was obtained by the reaction of 3-amino-2-benzyl-6-hydrazino-1,2,4-triazin-5(2H)-one (3) with carbon disulfide in a water/pyridine mixture. Compound 4 can also be synthesized by reacting 6-amino-3(2H)mercapto-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one (7) with b...

In the title mol-ecule, C(21)H(19)N(3)O(2), the central pyridine ring makes dihedral angles of 14.46 (9) and 34.67 (8)° with the 4-amino- and 4-eth-oxy-substituted benzene rings, respectively. The eth-oxy group is essentially coplanar with the attached benzene ring [C-O-C-C torsion angle = 178.70 (16)°] as is the meth-oxy group with the pyridine ring [C-O-C-N torsion angle = -3.0 (3)°]. In the ...

The title compound, C(15)H(16)N(4)O, was prepared by the reaction of pyridine-3-carbaldehyde with 4-dimethyl-amino-benzo-hydrazide in methanol. The dihedral angle between the pyridine and the benzene rings is 5.1 (3)°. In the crystal structure, the hydrazone mol-ecules are linked through inter-molecular N-H⋯O hydrogen bonds, forming chains along the b axis.

Objective(s):Involvement of tyrosinase in the synthesis of melanin and cell signaling pathway has made it an attractive target in the search for therapeutic inhibitors for treatment of different skin hyperpigmentation disorders and melanoma cancers. Materials and Methods: In the present study, we conducted a comprehensive kinetic analysis to understand the mechanisms of inhibition imposed by 2-...

Flupirtine is a centrally acting non-opioid analgesic; it has been in clinical use since 1984. The pharmacological and therapeutic properties of flupirtine in pain states have been reviewed extensively (7). The present review addresses new and challenging data that have been published during recent years. In particular, it has been discovered that flupirtine, in a clinically relevant dosage ran...